MHE April 2024

home / journals / mhe-publication / mhe-april-2024
Talking About the Generations:The health and healthcare of boomers, Gen Xers, millennials and Gen Zers. Part 4, Gen Z.

Talking About the Generations:The health and healthcare of boomers, Gen Xers, millennials and Gen Zers. Part 4, Gen Z.

Deborah Abrams Kaplan
April 16th 2024
Article

Generation Z (1997–2012). Everything on demand, including healthcare

Talking About the Generations: The Health and Healthcare of Boomers, Gen Xers, Millennials and Gen Zers. Part 3, Millennials

Talking About the Generations: The Health and Healthcare of Boomers, Gen Xers, Millennials and Gen Zers. Part 3, Millennials

Peter Wehrwein, Managing Editor
April 15th 2024
Article

Millennials (1981–1996), burdened by health problems and costly

headshot of Marci Chodroff, M.D.

A Conversation With Marci J. Chodroff, M.D.

Peter Wehrwein, Managing Editor
April 12th 2024
Article

On specialty drugs, the Prime acquisition and vertical integration

Talking About the Generations: The Health and Healthcare of Boomers, Gen Xers, millennials and Gen Zers. Part 2, Gen Xers

Talking About the Generations: The Health and Healthcare of Boomers, Gen Xers, millennials and Gen Zers. Part 2, Gen Xers

Deborah Abrams Kaplan
April 12th 2024
Article

Gen X (1965–1980), still traditional — and stuck in the middle.

Talking About the Generations: The Health and Healthcare of Boomers, Gen Xers, Millennials and Gen Zers. Part 1, The Boomers

Talking About the Generations: The Health and Healthcare of Boomers, Gen Xers, Millennials and Gen Zers. Part 1, The Boomers

Jared Kaltwasser
April 11th 2024
Article

The Boomers (1946–1964): Active but aging

AbbVie Plays Its Ace Cards Against Humira’s Decline

AbbVie Plays Its Ace Cards Against Humira’s Decline

Tony Hagen
April 10th 2024
Article

Ten biosimilars to Humira are now on the market, but AbbVie’s Skyrizi and Rinvoq are soaking up revenues as Humira’s sales fall off.

physician pointing at digital health icons | Image credit: Summit Art Creations stock.adobe.com

Investment in digital health? Definitely. ROI? Maybe.

Jared Kaltwasser
April 5th 2024
Article

The imperative to upgrade healthcare technology infrastructure is clear, but the returns from such investment are anything but.

Form on clipboard that says prior authorization form | Image credit: © syahrir stock.adobe.com

Speeding Up Prior Authorization, Healthcare’s Slowpoke

Susan Ladika
April 3rd 2024
Article

New federal rules set time requirements for some insurers.

© 2025 MJH Life Sciences

All rights reserved.